Hassan Mohammad
17Patents
6h-index
20Co-inventors
66Inventor score
Filing activity: Dec 27, 1996 → Nov 10, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5843480A | Controlled release diamorphine formulation | Human Necessities | 200 | Expired |
| US6399096B1 | Pharmaceutical formulation | Human Necessities | 137 | Expired |
| US8586083B2 | Gastroretentive drug delivery system comprising an extruded hydratable polymer | Human Necessities | 26 | Active |
| US9259872B2 | Multiparticulates | Human Necessities | 12 | Active |
| US8506998B2 | Pharmaceutical formulation | Human Necessities | 11 | Active |
| US8920836B2 | Particulates | Performing Operations; Transporting | 8 | Active |
| US9901540B2 | Combination of active loaded granules with additional actives | Human Necessities | 1 | Active |
| US9700508B2 | Pharmaceutical compositions comprising hydromorphone and naloxone | Human Necessities | 1 | Active |
| US9814679B2 | Tamper resistant dosage form comprising a matrix and melt-extruded particulates comprising a drug | Human Necessities | 1 | Active |
| US9814710B2 | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome | Human Necessities | 1 | Active |
| US9820983B2 | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | Human Necessities | 0 | Active |
| US9993433B2 | Manufacturing of active-free granules and tablets comprising the same | Human Necessities | 0 | Active |
| US9271940B2 | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | Human Necessities | 0 | Active |
| US9603802B2 | Extrusion | Emerging Cross-Sectional Technologies | 0 | Active |
| US9782359B2 | Opioid composition for treating skin lesions | Human Necessities | 0 | Active |
| US9034373B2 | Pharmaceutical spheroids | Human Necessities | 0 | Active |
| US10258616B2 | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.